Investing.com - Financial Markets Worldwide

Pliant Therapeutics Inc (PLRX)

NASDAQ
Symbol
Exchange
Currency
PLRX·NASDAQ·USD
9PT·TradeGate·EUR
Currency in USD
1.64
+0.02(+1.23%)
Closed·
After Hours
1.63-0.01(-0.61%)
·
PLRX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
PLRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Unlock Value
Day's Range
1.541.64
52 wk Range
1.1016.10
Key Statistics
Edit
Prev. Close
1.62
Open
1.62
Day's Range
1.54-1.64
52 wk Range
1.1-16.1
Volume
517.82K
Average Volume (3m)
1.25M
1-Year Change
-87.66%
Book Value / Share
3.59
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PLRX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
2.96
Upside
+80.31%
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 12
Quickly burning through cash
Unlock InvestingPro

Pliant Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Pliant Therapeutics Inc Company Profile

Pliant Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases. The company’s lead candidate includes bexotegrast, an oral, small-molecule, dual selective inhibitor of avß6 and avß1 integrins, which has completed phase 2a trial for primary sclerosing cholangitis. It also develops PLN-1474, an oral, small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis; PLN-101095, a dual inhibitor of integrins avß8 and avß1 for the treatment of solid tumors; and PLN-101325, a phase 1-ready program for treatment of the muscular dystrophies, including duchenne muscular dystrophy. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Industry
Pharmaceuticals
Sector
Healthcare
Employees
171
Market
United States

Compare PLRX to Peers and Sector

Metrics to compare
PLRX
Peers
Sector
Relationship
P/E Ratio
−0.5x−0.4x−0.5x
PEG Ratio
0.050.100.00
Price/Book
0.5x2.2x2.6x
Price / LTM Sales
-1.8x3.2x
Upside (Analyst Target)
82.9%94.2%38.8%
Fair Value Upside
Unlock13.3%5.4%Unlock

Analyst Ratings

2 Buy
10 Hold
0 Sell
Ratings:
12 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 2.96
(+80.31% Upside)

Earnings

Latest Release
Aug 07, 2025
EPS / Forecast
-0.71 / -0.6595
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

PLRX Income Statement

People Also Watch

Sarepta
18.20
SRPT
-0.76%
Sequans Communications
0.898
SQNS
-1.43%
Esperion
2.220
ESPR
+0.45%
Soligenix Inc
3.1000
SNGX
+1.31%
Precigen
4.510
PGEN
-0.88%

FAQ

What Stock Exchange Does Pliant Trade On?

Pliant is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Pliant?

The stock symbol for Pliant is "PLRX."

What Is the Pliant Market Cap?

As of today, Pliant market cap is 100.68M.

What Is Pliant's Earnings Per Share (TTM)?

The Pliant EPS (TTM) is -3.39.

When Is the Next Pliant Earnings Date?

Pliant will release its next earnings report on 10 Nov 2025.

From a Technical Analysis Perspective, Is PLRX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Pliant Stock Split?

Pliant has split 0 times.

How Many Employees Does Pliant Have?

Pliant has 171 employees.

What is the current trading status of Pliant (PLRX)?

As of 31 Aug 2025, Pliant (PLRX) is trading at a price of 1.64, with a previous close of 1.62. The stock has fluctuated within a day range of 1.54 to 1.64, while its 52-week range spans from 1.10 to 16.10.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.